Literature DB >> 10375681

Actions of 5-HT on human neocortical neurones in vitro.

N R Newberry1, D R Footitt, V Papanastassiou, D J Reynolds.   

Abstract

Using intracellular recordings, we have studied the action of 5-hydroxytryptamine (5-HT) on slices of human temporal, occipital and frontal cortex maintained in vitro. The recordings were usually made 1.2 to 1.5 mm down from the pial surface, in or around layer III. The action of 5-HT (30-50 microM) was studied on 21 cells (from 12 individuals) which had electrophysiological characteristics of glutamatergic pyramidal neurones. 5-HT depolarised the majority (11) of these cells with a median response of 5 mV. It produced a hyperpolarising response in five neurones (median=-4 mV) and a combined hyperpolarising/depolarising response in two others. No response was detected in three cells. The depolarising response was probably mediated by reducing a resting potassium conductance. Ketanserin (0.1 and 1.0 microM) and spiperone (1 microM) reduced the response indicating that it was likely mediated by 5-HT2A receptors. The hyperpolarising response was associated with the opening of ion channels and was blocked by the selective 5-HT1A receptor antagonist WAY-100635 (100 nM). 5-HT inhibited spontaneous synaptic potentials. This effect was reduced by ketanserin (1 microM) but not by WAY-100635 (100 nM). It is concluded that human neocortical neurones in vitro can be depolarised via 5-HT2A receptors and hyperpolarised via 5-HT1A receptors. Copyright 1999 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10375681     DOI: 10.1016/s0006-8993(99)01540-1

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  8 in total

1.  Serotonergic modulation of supragranular neurons in rat sensorimotor cortex.

Authors:  R C Foehring; J F M van Brederode; G A Kinney; W J Spain
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

2.  Serotonin inhibition of the NMDA receptor/nitric oxide/cyclic GMP pathway in human neocortex slices: involvement of 5-HT(2C) and 5-HT(1A) receptors.

Authors:  G Maura; M Marcoli; O Pepicelli; C Rosu; C Viola; M Raiteri
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

3.  GABA Targets for the Treatment of Cognitive Dysfunction in Schizophrenia.

Authors:  David W Volk; David A Lewis
Journal:  Curr Neuropharmacol       Date:  2005-01       Impact factor: 7.363

4.  Fluoxetine (prozac) and serotonin act on excitatory synaptic transmission to suppress single layer 2/3 pyramidal neuron-triggered cell assemblies in the human prefrontal cortex.

Authors:  Gergely Komlósi; Gábor Molnár; Márton Rózsa; Szabolcs Oláh; Pál Barzó; Gábor Tamás
Journal:  J Neurosci       Date:  2012-11-14       Impact factor: 6.167

Review 5.  The therapeutic role of 5-HT1A and 5-HT2A receptors in depression.

Authors:  Pau Celada; M Puig; Mercè Amargós-Bosch; Albert Adell; Francesc Artigas
Journal:  J Psychiatry Neurosci       Date:  2004-07       Impact factor: 6.186

Review 6.  A Dendrite-Focused Framework for Understanding the Actions of Ketamine and Psychedelics.

Authors:  Neil K Savalia; Ling-Xiao Shao; Alex C Kwan
Journal:  Trends Neurosci       Date:  2020-12-21       Impact factor: 13.837

7.  Serotonin modulation of cortical neurons and networks.

Authors:  Pau Celada; M Victoria Puig; Francesc Artigas
Journal:  Front Integr Neurosci       Date:  2013-04-19

8.  Psilocybin reduces low frequency oscillatory power and neuronal phase-locking in the anterior cingulate cortex of awake rodents.

Authors:  Caroline T Golden; Paul Chadderton
Journal:  Sci Rep       Date:  2022-07-26       Impact factor: 4.996

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.